Table of Content

1 Docetaxel Injection Market Overview
1.1 Product Overview and Scope of Docetaxel Injection
1.2 Docetaxel Injection Segment by Type
1.2.1 Global Docetaxel Injection Market Value Comparison by Type (2024-2034)
1.2.2 10mg/ml
1.2.3 20mg/ml
1.2.4 40mg/ml
1.2.5 Others
1.3 Docetaxel Injection Segment by Application
1.3.1 Global Docetaxel Injection Market Value by Application: (2024-2034)
1.3.2 Adenocarcinoma
1.3.3 Non-small Cell Tumor
1.3.4 Lung Cancer
1.3.5 Ovarian Cancer
1.3.6 Pancreatic Cancer
1.3.7 Stomach Cancer
1.3.8 Head and Neck Cancer
1.3.9 Others
1.4 Global Docetaxel Injection Market Size Estimates and Forecasts
1.4.1 Global Docetaxel Injection Revenue 2018-2029
1.4.2 Global Docetaxel Injection Sales 2018-2029
1.4.3 Global Docetaxel Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Docetaxel Injection Market Competition by Manufacturers
2.1 Global Docetaxel Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Docetaxel Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Docetaxel Injection Average Price by Manufacturers (2018-2024)
2.4 Global Docetaxel Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Docetaxel Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Docetaxel Injection, Product Type & Application
2.7 Docetaxel Injection Market Competitive Situation and Trends
2.7.1 Docetaxel Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Docetaxel Injection Players Market Share by Revenue
2.7.3 Global Docetaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Docetaxel Injection Retrospective Market Scenario by Region
3.1 Global Docetaxel Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Docetaxel Injection Global Docetaxel Injection Sales by Region: 2018-2029
3.2.1 Global Docetaxel Injection Sales by Region: 2018-2024
3.2.2 Global Docetaxel Injection Sales by Region: 2024-2029
3.3 Global Docetaxel Injection Global Docetaxel Injection Revenue by Region: 2018-2029
3.3.1 Global Docetaxel Injection Revenue by Region: 2018-2024
3.3.2 Global Docetaxel Injection Revenue by Region: 2024-2029
3.4 North America Docetaxel Injection Market Facts & Figures by Country
3.4.1 North America Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Docetaxel Injection Sales by Country (2018-2029)
3.4.3 North America Docetaxel Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Docetaxel Injection Market Facts & Figures by Country
3.5.1 Europe Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Docetaxel Injection Sales by Country (2018-2029)
3.5.3 Europe Docetaxel Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Docetaxel Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Docetaxel Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Docetaxel Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Docetaxel Injection Market Facts & Figures by Country
3.7.1 Latin America Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Docetaxel Injection Sales by Country (2018-2029)
3.7.3 Latin America Docetaxel Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Docetaxel Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Docetaxel Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Docetaxel Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Docetaxel Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Docetaxel Injection Sales by Type (2018-2029)
4.1.1 Global Docetaxel Injection Sales by Type (2018-2024)
4.1.2 Global Docetaxel Injection Sales by Type (2024-2029)
4.1.3 Global Docetaxel Injection Sales Market Share by Type (2018-2029)
4.2 Global Docetaxel Injection Revenue by Type (2018-2029)
4.2.1 Global Docetaxel Injection Revenue by Type (2018-2024)
4.2.2 Global Docetaxel Injection Revenue by Type (2024-2029)
4.2.3 Global Docetaxel Injection Revenue Market Share by Type (2018-2029)
4.3 Global Docetaxel Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Docetaxel Injection Sales by Application (2018-2029)
5.1.1 Global Docetaxel Injection Sales by Application (2018-2024)
5.1.2 Global Docetaxel Injection Sales by Application (2024-2029)
5.1.3 Global Docetaxel Injection Sales Market Share by Application (2018-2029)
5.2 Global Docetaxel Injection Revenue by Application (2018-2029)
5.2.1 Global Docetaxel Injection Revenue by Application (2018-2024)
5.2.2 Global Docetaxel Injection Revenue by Application (2024-2029)
5.2.3 Global Docetaxel Injection Revenue Market Share by Application (2018-2029)
5.3 Global Docetaxel Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sanofi Docetaxel Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Corporation Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Accord Healthcare Docetaxel Injection Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Alkem Labs
6.3.1 Alkem Labs Corporation Information
6.3.2 Alkem Labs Description and Business Overview
6.3.3 Alkem Labs Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Alkem Labs Docetaxel Injection Product Portfolio
6.3.5 Alkem Labs Recent Developments/Updates
6.4 AuroMedics Pharma
6.4.1 AuroMedics Pharma Corporation Information
6.4.2 AuroMedics Pharma Description and Business Overview
6.4.3 AuroMedics Pharma Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 AuroMedics Pharma Docetaxel Injection Product Portfolio
6.4.5 AuroMedics Pharma Recent Developments/Updates
6.5 Dr. Reddy’s Laboratories
6.5.1 Dr. Reddy’s Laboratories Corporation Information
6.5.2 Dr. Reddy’s Laboratories Description and Business Overview
6.5.3 Dr. Reddy’s Laboratories Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Dr. Reddy’s Laboratories Docetaxel Injection Product Portfolio
6.5.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Fresenius Kabi Docetaxel Injection Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Getwell Oncology
6.6.1 Getwell Oncology Corporation Information
6.6.2 Getwell Oncology Description and Business Overview
6.6.3 Getwell Oncology Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Getwell Oncology Docetaxel Injection Product Portfolio
6.7.5 Getwell Oncology Recent Developments/Updates
6.8 GLS Pharma
6.8.1 GLS Pharma Corporation Information
6.8.2 GLS Pharma Description and Business Overview
6.8.3 GLS Pharma Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.8.4 GLS Pharma Docetaxel Injection Product Portfolio
6.8.5 GLS Pharma Recent Developments/Updates
6.9 Hikma
6.9.1 Hikma Corporation Information
6.9.2 Hikma Description and Business Overview
6.9.3 Hikma Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Hikma Docetaxel Injection Product Portfolio
6.9.5 Hikma Recent Developments/Updates
6.10 Hospira
6.10.1 Hospira Corporation Information
6.10.2 Hospira Description and Business Overview
6.10.3 Hospira Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Hospira Docetaxel Injection Product Portfolio
6.10.5 Hospira Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Docetaxel Injection Description and Business Overview
6.11.3 Pfizer Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Pfizer Docetaxel Injection Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Seacross Pharmaceuticals
6.12.1 Seacross Pharmaceuticals Corporation Information
6.12.2 Seacross Pharmaceuticals Docetaxel Injection Description and Business Overview
6.12.3 Seacross Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Seacross Pharmaceuticals Docetaxel Injection Product Portfolio
6.12.5 Seacross Pharmaceuticals Recent Developments/Updates
6.13 Teikoku Pharma USA
6.13.1 Teikoku Pharma USA Corporation Information
6.13.2 Teikoku Pharma USA Docetaxel Injection Description and Business Overview
6.13.3 Teikoku Pharma USA Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Teikoku Pharma USA Docetaxel Injection Product Portfolio
6.13.5 Teikoku Pharma USA Recent Developments/Updates
6.14 Teva Pharmaceuticals USA
6.14.1 Teva Pharmaceuticals USA Corporation Information
6.14.2 Teva Pharmaceuticals USA Docetaxel Injection Description and Business Overview
6.14.3 Teva Pharmaceuticals USA Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Teva Pharmaceuticals USA Docetaxel Injection Product Portfolio
6.14.5 Teva Pharmaceuticals USA Recent Developments/Updates
6.15 Xiromed
6.15.1 Xiromed Corporation Information
6.15.2 Xiromed Docetaxel Injection Description and Business Overview
6.15.3 Xiromed Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Xiromed Docetaxel Injection Product Portfolio
6.15.5 Xiromed Recent Developments/Updates
6.16 Aosaikang Pharmaceutical
6.16.1 Aosaikang Pharmaceutical Corporation Information
6.16.2 Aosaikang Pharmaceutical Docetaxel Injection Description and Business Overview
6.16.3 Aosaikang Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Aosaikang Pharmaceutical Docetaxel Injection Product Portfolio
6.16.5 Aosaikang Pharmaceutical Recent Developments/Updates
6.17 Beijing Union Pharmaceutical Factory
6.17.1 Beijing Union Pharmaceutical Factory Corporation Information
6.17.2 Beijing Union Pharmaceutical Factory Docetaxel Injection Description and Business Overview
6.17.3 Beijing Union Pharmaceutical Factory Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Beijing Union Pharmaceutical Factory Docetaxel Injection Product Portfolio
6.17.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
6.18 Cisen Pharmaceutical
6.18.1 Cisen Pharmaceutical Corporation Information
6.18.2 Cisen Pharmaceutical Docetaxel Injection Description and Business Overview
6.18.3 Cisen Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Cisen Pharmaceutical Docetaxel Injection Product Portfolio
6.18.5 Cisen Pharmaceutical Recent Developments/Updates
6.19 Acebright Pharmaceuticals
6.19.1 Acebright Pharmaceuticals Corporation Information
6.19.2 Acebright Pharmaceuticals Docetaxel Injection Description and Business Overview
6.19.3 Acebright Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Acebright Pharmaceuticals Docetaxel Injection Product Portfolio
6.19.5 Acebright Pharmaceuticals Recent Developments/Updates
6.20 Hisun Pharmaceutical
6.20.1 Hisun Pharmaceutical Corporation Information
6.20.2 Hisun Pharmaceutical Docetaxel Injection Description and Business Overview
6.20.3 Hisun Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Hisun Pharmaceutical Docetaxel Injection Product Portfolio
6.20.5 Hisun Pharmaceutical Recent Developments/Updates
6.21 Hanhui Pharmaceutical
6.21.1 Hanhui Pharmaceutical Corporation Information
6.21.2 Hanhui Pharmaceutical Docetaxel Injection Description and Business Overview
6.21.3 Hanhui Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Hanhui Pharmaceutical Docetaxel Injection Product Portfolio
6.21.5 Hanhui Pharmaceutical Recent Developments/Updates
6.22 Hengrui Pharmaceuticals
6.22.1 Hengrui Pharmaceuticals Corporation Information
6.22.2 Hengrui Pharmaceuticals Docetaxel Injection Description and Business Overview
6.22.3 Hengrui Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Hengrui Pharmaceuticals Docetaxel Injection Product Portfolio
6.22.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.23 Meida Kangjiale
6.23.1 Meida Kangjiale Corporation Information
6.23.2 Meida Kangjiale Docetaxel Injection Description and Business Overview
6.23.3 Meida Kangjiale Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Meida Kangjiale Docetaxel Injection Product Portfolio
6.23.5 Meida Kangjiale Recent Developments/Updates
6.24 Qilu Pharmaceutical
6.24.1 Qilu Pharmaceutical Corporation Information
6.24.2 Qilu Pharmaceutical Docetaxel Injection Description and Business Overview
6.24.3 Qilu Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Qilu Pharmaceutical Docetaxel Injection Product Portfolio
6.24.5 Qilu Pharmaceutical Recent Developments/Updates
6.25 Taiji Pharmaceutical
6.25.1 Taiji Pharmaceutical Corporation Information
6.25.2 Taiji Pharmaceutical Docetaxel Injection Description and Business Overview
6.25.3 Taiji Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.25.4 Taiji Pharmaceutical Docetaxel Injection Product Portfolio
6.25.5 Taiji Pharmaceutical Recent Developments/Updates
6.26 Wansheng Pharmaceutical
6.26.1 Wansheng Pharmaceutical Corporation Information
6.26.2 Wansheng Pharmaceutical Docetaxel Injection Description and Business Overview
6.26.3 Wansheng Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.26.4 Wansheng Pharmaceutical Docetaxel Injection Product Portfolio
6.26.5 Wansheng Pharmaceutical Recent Developments/Updates
6.27 Main Luck Pharmaceuticals
6.27.1 Main Luck Pharmaceuticals Corporation Information
6.27.2 Main Luck Pharmaceuticals Docetaxel Injection Description and Business Overview
6.27.3 Main Luck Pharmaceuticals Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.27.4 Main Luck Pharmaceuticals Docetaxel Injection Product Portfolio
6.27.5 Main Luck Pharmaceuticals Recent Developments/Updates
6.28 Yangtze River Pharmaceutical
6.28.1 Yangtze River Pharmaceutical Corporation Information
6.28.2 Yangtze River Pharmaceutical Docetaxel Injection Description and Business Overview
6.28.3 Yangtze River Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.28.4 Yangtze River Pharmaceutical Docetaxel Injection Product Portfolio
6.28.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.29 Chia Tal-tianqing Pharmaceutical
6.29.1 Chia Tal-tianqing Pharmaceutical Corporation Information
6.29.2 Chia Tal-tianqing Pharmaceutical Docetaxel Injection Description and Business Overview
6.29.3 Chia Tal-tianqing Pharmaceutical Docetaxel Injection Sales, Revenue and Gross Margin (2018-2024)
6.29.4 Chia Tal-tianqing Pharmaceutical Docetaxel Injection Product Portfolio
6.29.5 Chia Tal-tianqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Docetaxel Injection Industry Chain Analysis
7.2 Docetaxel Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Docetaxel Injection Production Mode & Process
7.4 Docetaxel Injection Sales and Marketing
7.4.1 Docetaxel Injection Sales Channels
7.4.2 Docetaxel Injection Distributors
7.5 Docetaxel Injection Customers
8 Docetaxel Injection Market Dynamics
8.1 Docetaxel Injection Industry Trends
8.2 Docetaxel Injection Market Drivers
8.3 Docetaxel Injection Market Challenges
8.4 Docetaxel Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Docetaxel Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Docetaxel Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Docetaxel Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Docetaxel Injection Sales (K L) of Key Manufacturers (2018-2024)
Table 5. Global Docetaxel Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Docetaxel Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Docetaxel Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Docetaxel Injection Average Price (US$/L) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Docetaxel Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Docetaxel Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Docetaxel Injection, Product Type & Application
Table 12. Global Key Manufacturers of Docetaxel Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Docetaxel Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Docetaxel Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Docetaxel Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Docetaxel Injection Sales by Region (2018-2024) & (K L)
Table 18. Global Docetaxel Injection Sales Market Share by Region (2018-2024)
Table 19. Global Docetaxel Injection Sales by Region (2024-2029) & (K L)
Table 20. Global Docetaxel Injection Sales Market Share by Region (2024-2029)
Table 21. Global Docetaxel Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Docetaxel Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Docetaxel Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Docetaxel Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Docetaxel Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Docetaxel Injection Sales by Country (2018-2024) & (K L)
Table 27. North America Docetaxel Injection Sales by Country (2024-2029) & (K L)
Table 28. North America Docetaxel Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Docetaxel Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Docetaxel Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Docetaxel Injection Sales by Country (2018-2024) & (K L)
Table 32. Europe Docetaxel Injection Sales by Country (2024-2029) & (K L)
Table 33. Europe Docetaxel Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Docetaxel Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Docetaxel Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Docetaxel Injection Sales by Region (2018-2024) & (K L)
Table 37. Asia Pacific Docetaxel Injection Sales by Region (2024-2029) & (K L)
Table 38. Asia Pacific Docetaxel Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Docetaxel Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Docetaxel Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Docetaxel Injection Sales by Country (2018-2024) & (K L)
Table 42. Latin America Docetaxel Injection Sales by Country (2024-2029) & (K L)
Table 43. Latin America Docetaxel Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Docetaxel Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Docetaxel Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Docetaxel Injection Sales by Country (2018-2024) & (K L)
Table 47. Middle East & Africa Docetaxel Injection Sales by Country (2024-2029) & (K L)
Table 48. Middle East & Africa Docetaxel Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Docetaxel Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Docetaxel Injection Sales (K L) by Type (2018-2024)
Table 51. Global Docetaxel Injection Sales (K L) by Type (2024-2029)
Table 52. Global Docetaxel Injection Sales Market Share by Type (2018-2024)
Table 53. Global Docetaxel Injection Sales Market Share by Type (2024-2029)
Table 54. Global Docetaxel Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Docetaxel Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Docetaxel Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Docetaxel Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Docetaxel Injection Price (US$/L) by Type (2018-2024)
Table 59. Global Docetaxel Injection Price (US$/L) by Type (2024-2029)
Table 60. Global Docetaxel Injection Sales (K L) by Application (2018-2024)
Table 61. Global Docetaxel Injection Sales (K L) by Application (2024-2029)
Table 62. Global Docetaxel Injection Sales Market Share by Application (2018-2024)
Table 63. Global Docetaxel Injection Sales Market Share by Application (2024-2029)
Table 64. Global Docetaxel Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Docetaxel Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Docetaxel Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Docetaxel Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Docetaxel Injection Price (US$/L) by Application (2018-2024)
Table 69. Global Docetaxel Injection Price (US$/L) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 73. Sanofi Docetaxel Injection Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Accord Healthcare Corporation Information
Table 76. Accord Healthcare Description and Business Overview
Table 77. Accord Healthcare Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 78. Accord Healthcare Docetaxel Injection Product
Table 79. Accord Healthcare Recent Developments/Updates
Table 80. Alkem Labs Corporation Information
Table 81. Alkem Labs Description and Business Overview
Table 82. Alkem Labs Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 83. Alkem Labs Docetaxel Injection Product
Table 84. Alkem Labs Recent Developments/Updates
Table 85. AuroMedics Pharma Corporation Information
Table 86. AuroMedics Pharma Description and Business Overview
Table 87. AuroMedics Pharma Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 88. AuroMedics Pharma Docetaxel Injection Product
Table 89. AuroMedics Pharma Recent Developments/Updates
Table 90. Dr. Reddy’s Laboratories Corporation Information
Table 91. Dr. Reddy’s Laboratories Description and Business Overview
Table 92. Dr. Reddy’s Laboratories Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 93. Dr. Reddy’s Laboratories Docetaxel Injection Product
Table 94. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 95. Fresenius Kabi Corporation Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 98. Fresenius Kabi Docetaxel Injection Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Getwell Oncology Corporation Information
Table 101. Getwell Oncology Description and Business Overview
Table 102. Getwell Oncology Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 103. Getwell Oncology Docetaxel Injection Product
Table 104. Getwell Oncology Recent Developments/Updates
Table 105. GLS Pharma Corporation Information
Table 106. GLS Pharma Description and Business Overview
Table 107. GLS Pharma Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 108. GLS Pharma Docetaxel Injection Product
Table 109. GLS Pharma Recent Developments/Updates
Table 110. Hikma Corporation Information
Table 111. Hikma Description and Business Overview
Table 112. Hikma Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 113. Hikma Docetaxel Injection Product
Table 114. Hikma Recent Developments/Updates
Table 115. Hospira Corporation Information
Table 116. Hospira Description and Business Overview
Table 117. Hospira Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 118. Hospira Docetaxel Injection Product
Table 119. Hospira Recent Developments/Updates
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 123. Pfizer Docetaxel Injection Product
Table 124. Pfizer Recent Developments/Updates
Table 125. Seacross Pharmaceuticals Corporation Information
Table 126. Seacross Pharmaceuticals Description and Business Overview
Table 127. Seacross Pharmaceuticals Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 128. Seacross Pharmaceuticals Docetaxel Injection Product
Table 129. Seacross Pharmaceuticals Recent Developments/Updates
Table 130. Teikoku Pharma USA Corporation Information
Table 131. Teikoku Pharma USA Description and Business Overview
Table 132. Teikoku Pharma USA Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 133. Teikoku Pharma USA Docetaxel Injection Product
Table 134. Teikoku Pharma USA Recent Developments/Updates
Table 135. Teva Pharmaceuticals USA Corporation Information
Table 136. Teva Pharmaceuticals USA Description and Business Overview
Table 137. Teva Pharmaceuticals USA Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 138. Teva Pharmaceuticals USA Docetaxel Injection Product
Table 139. Teva Pharmaceuticals USA Recent Developments/Updates
Table 140. Xiromed Corporation Information
Table 141. Xiromed Description and Business Overview
Table 142. Xiromed Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 143. Xiromed Docetaxel Injection Product
Table 144. Xiromed Recent Developments/Updates
Table 145. Aosaikang Pharmaceutical Corporation Information
Table 146. Aosaikang Pharmaceutical Description and Business Overview
Table 147. Aosaikang Pharmaceutical Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 148. Aosaikang Pharmaceutical Docetaxel Injection Product
Table 149. Aosaikang Pharmaceutical Recent Developments/Updates
Table 150. Beijing Union Pharmaceutical Factory Corporation Information
Table 151. Beijing Union Pharmaceutical Factory Description and Business Overview
Table 152. Beijing Union Pharmaceutical Factory Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 153. Beijing Union Pharmaceutical Factory Docetaxel Injection Product
Table 154. Beijing Union Pharmaceutical Factory Recent Developments/Updates
Table 155. Cisen Pharmaceutical Corporation Information
Table 156. Cisen Pharmaceutical Description and Business Overview
Table 157. Cisen Pharmaceutical Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 158. Cisen Pharmaceutical Docetaxel Injection Product
Table 159. Cisen Pharmaceutical Recent Developments/Updates
Table 160. Acebright Pharmaceuticals Corporation Information
Table 161. Acebright Pharmaceuticals Description and Business Overview
Table 162. Acebright Pharmaceuticals Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 163. Acebright Pharmaceuticals Docetaxel Injection Product
Table 164. Acebright Pharmaceuticals Recent Developments/Updates
Table 165. Hisun Pharmaceutical Corporation Information
Table 166. Hisun Pharmaceutical Description and Business Overview
Table 167. Hisun Pharmaceutical Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 168. Hisun Pharmaceutical Docetaxel Injection Product
Table 169. Hisun Pharmaceutical Recent Developments/Updates
Table 170. Hanhui Pharmaceutical Corporation Information
Table 171. Hanhui Pharmaceutical Description and Business Overview
Table 172. Hanhui Pharmaceutical Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 173. Hanhui Pharmaceutical Docetaxel Injection Product
Table 174. Hanhui Pharmaceutical Recent Developments/Updates
Table 175. Hengrui Pharmaceuticals Corporation Information
Table 176. Hengrui Pharmaceuticals Description and Business Overview
Table 177. Hengrui Pharmaceuticals Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 178. Hengrui Pharmaceuticals Docetaxel Injection Product
Table 179. Hengrui Pharmaceuticals Recent Developments/Updates
Table 180. Meida Kangjiale Corporation Information
Table 181. Meida Kangjiale Description and Business Overview
Table 182. Meida Kangjiale Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 183. Meida Kangjiale Docetaxel Injection Product
Table 184. Meida Kangjiale Recent Developments/Updates
Table 185. Qilu Pharmaceutical Corporation Information
Table 186. Qilu Pharmaceutical Description and Business Overview
Table 187. Qilu Pharmaceutical Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 188. Qilu Pharmaceutical Docetaxel Injection Product
Table 189. Qilu Pharmaceutical Recent Developments/Updates
Table 190. Taiji Pharmaceutical Corporation Information
Table 191. Taiji Pharmaceutical Description and Business Overview
Table 192. Taiji Pharmaceutical Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 193. Taiji Pharmaceutical Docetaxel Injection Product
Table 194. Taiji Pharmaceutical Recent Developments/Updates
Table 195. Wansheng Pharmaceutical Corporation Information
Table 196. Wansheng Pharmaceutical Description and Business Overview
Table 197. Wansheng Pharmaceutical Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 198. Wansheng Pharmaceutical Docetaxel Injection Product
Table 199. Wansheng Pharmaceutical Recent Developments/Updates
Table 200. Main Luck Pharmaceuticals Corporation Information
Table 201. Main Luck Pharmaceuticals Description and Business Overview
Table 202. Main Luck Pharmaceuticals Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 203. Main Luck Pharmaceuticals Docetaxel Injection Product
Table 204. Main Luck Pharmaceuticals Recent Developments/Updates
Table 205. Yangtze River Pharmaceutical Corporation Information
Table 206. Yangtze River Pharmaceutical Description and Business Overview
Table 207. Yangtze River Pharmaceutical Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 208. Yangtze River Pharmaceutical Docetaxel Injection Product
Table 209. Yangtze River Pharmaceutical Recent Developments/Updates
Table 210. Chia Tal-tianqing Pharmaceutical Corporation Information
Table 211. Chia Tal-tianqing Pharmaceutical Description and Business Overview
Table 212. Chia Tal-tianqing Pharmaceutical Docetaxel Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 213. Chia Tal-tianqing Pharmaceutical Docetaxel Injection Product
Table 214. Chia Tal-tianqing Pharmaceutical Recent Developments/Updates
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Docetaxel Injection Distributors List
Table 218. Docetaxel Injection Customers List
Table 219. Docetaxel Injection Market Trends
Table 220. Docetaxel Injection Market Drivers
Table 221. Docetaxel Injection Market Challenges
Table 222. Docetaxel Injection Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Docetaxel Injection
Figure 2. Global Docetaxel Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Docetaxel Injection Market Share by Type in 2022 & 2029
Figure 4. 10mg/ml Product Picture
Figure 5. 20mg/ml Product Picture
Figure 6. 40mg/ml Product Picture
Figure 7. Others Product Picture
Figure 8. Global Docetaxel Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Docetaxel Injection Market Share by Application in 2022 & 2029
Figure 10. Adenocarcinoma
Figure 11. Non-small Cell Tumor
Figure 12. Lung Cancer
Figure 13. Ovarian Cancer
Figure 14. Pancreatic Cancer
Figure 15. Stomach Cancer
Figure 16. Head and Neck Cancer
Figure 17. Others
Figure 18. Global Docetaxel Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Docetaxel Injection Market Size (2018-2029) & (US$ Million)
Figure 20. Global Docetaxel Injection Sales (2018-2029) & (K L)
Figure 21. Global Docetaxel Injection Average Price (US$/L) & (2018-2029)
Figure 22. Docetaxel Injection Report Years Considered
Figure 23. Docetaxel Injection Sales Share by Manufacturers in 2022
Figure 24. Global Docetaxel Injection Revenue Share by Manufacturers in 2022
Figure 25. The Global 5 and 10 Largest Docetaxel Injection Players: Market Share by Revenue in 2022
Figure 26. Docetaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 27. Global Docetaxel Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 28. North America Docetaxel Injection Sales Market Share by Country (2018-2029)
Figure 29. North America Docetaxel Injection Revenue Market Share by Country (2018-2029)
Figure 30. U.S. Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Canada Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Europe Docetaxel Injection Sales Market Share by Country (2018-2029)
Figure 33. Europe Docetaxel Injection Revenue Market Share by Country (2018-2029)
Figure 34. Germany Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. France Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. U.K. Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Italy Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Russia Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Asia Pacific Docetaxel Injection Sales Market Share by Region (2018-2029)
Figure 40. Asia Pacific Docetaxel Injection Revenue Market Share by Region (2018-2029)
Figure 41. China Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Taiwan Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Philippines Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Latin America Docetaxel Injection Sales Market Share by Country (2018-2029)
Figure 52. Latin America Docetaxel Injection Revenue Market Share by Country (2018-2029)
Figure 53. Mexico Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Brazil Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Argentina Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa Docetaxel Injection Sales Market Share by Country (2018-2029)
Figure 57. Middle East & Africa Docetaxel Injection Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. U.A.E Docetaxel Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Sales Market Share of Docetaxel Injection by Type (2018-2029)
Figure 62. Global Revenue Market Share of Docetaxel Injection by Type (2018-2029)
Figure 63. Global Docetaxel Injection Price (US$/L) by Type (2018-2029)
Figure 64. Global Sales Market Share of Docetaxel Injection by Application (2018-2029)
Figure 65. Global Revenue Market Share of Docetaxel Injection by Application (2018-2029)
Figure 66. Global Docetaxel Injection Price (US$/L) by Application (2018-2029)
Figure 67. Docetaxel Injection Value Chain
Figure 68. Docetaxel Injection Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed